<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of this experiment was to establish whether <z:chebi fb="1" ids="9948">verapamil</z:chebi>, nicardipine, and <z:chebi fb="0" ids="28787">nitroglycerin</z:chebi> have (1) <z:mpath ids='MPATH_124'>infarct</z:mpath> size-limiting effects and (2) antiarrhythmic effects in in vivo rabbit hearts during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion </plain></SENT>
<SENT sid="1" pm="."><plain>Rabbits received regional <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> by 30 min of left anterior descending coronary <z:mp ids='MP_0006134'>artery occlusion</z:mp> followed by 3 hours of reperfusion under ketamine and xylazine anesthesia </plain></SENT>
<SENT sid="2" pm="."><plain>The animals were randomly assigned to the following 4 treatment groups: a control group, a <z:chebi fb="1" ids="9948">verapamil</z:chebi> group, a nicardipine group, and a <z:chebi fb="0" ids="28787">nitroglycerin</z:chebi> group </plain></SENT>
<SENT sid="3" pm="."><plain>A continuous infusion of <z:chebi fb="1" ids="9948">verapamil</z:chebi>, nicardipine, or <z:chebi fb="0" ids="28787">nitroglycerin</z:chebi> was initiated 5 min prior to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> size/area at risk decreased in <z:chebi fb="1" ids="9948">verapamil</z:chebi>, and <z:chebi fb="0" ids="28787">nitroglycerin</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>The incidence of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> decreased in nicardipine, <z:chebi fb="1" ids="9948">verapamil</z:chebi> and <z:chebi fb="0" ids="28787">nitroglycerin</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>The incidence of reperfusion-induced <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> decreased in <z:chebi fb="1" ids="9948">verapamil</z:chebi> and <z:chebi fb="0" ids="28787">nitroglycerin</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>From the present experimental results, <z:chebi fb="1" ids="9948">verapamil</z:chebi> and <z:chebi fb="0" ids="28787">nitroglycerin</z:chebi> rather than nicardipine did afford significant protection to the heart subjected to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and reperfusion in a rabbit model </plain></SENT>
</text></document>